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epinephrine; fasting; muscle atrophy; protein degradation; cAMP ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM (SNS) results in the targeted release of norepinephrine (NE) from peripheral nerve endings as well as the hormonal release of epinephrine from the adrenal medulla. The precise contribution of the neural and hormonal components to the regulation of catecholamine-dependent processes depends on the context and type of the stimulus (37) . It is well established that sympathetic activity in different tissues is reduced by fasting, an effect that may contribute to a decrease in the metabolic rate under conditions of caloric restriction. Conversely, the adrenal medulla is stimulated or remains unaltered during fasting (50) .
Although this stimulation of epinephrine secretion is modest, it may contribute to substrate mobilization, particularly by facilitating the hydrolysis of triglycerides in adipose tissue and by aiding glycogenolysis in liver and skeletal muscle (6) . However, the physiological role of epinephrine in the regulation of skeletal muscle protein metabolism during fasting is unknown.
Important adaptations of skeletal muscle under fasting conditions include the activation of proteolysis and the reduction of protein synthesis to support liver gluconeogenesis and the energy requirements of the organism. These adaptive changes in muscle protein metabolism are signaled by low levels of circulating insulin and high levels of glucocorticoids (20) and are more pronounced in fast-twitch muscles [e.g., extensor digitorum longus (EDL) and tibialis anterior] than in slowtwitch muscles (e.g., soleus) (25) . When fasting is prolonged, protein catabolism decreases to protect against excessive muscle wasting, and energy is derived from lipolysis. However, the mechanisms underlying this protein-sparing process have not been completely elucidated.
The ubiquitin (Ub)-proteasome system (UPS) is the main proteolytic system activated in starvation, and it catalyzes the bulk of muscle protein degradation, especially that of myofibrillar components (24) . During starvation conditions, muscle protein is rapidly mobilized through a common program of changes in gene expression, affecting ϳ100 atrophy-related genes, or atrogenes (23) . Muscle-specific Ub-ligases (E3s), atrogin-1/MAFbx (muscle atrophy F-box), and MuRF1 (muscle RING finger-1) are atrogenes that are induced prior to the onset of muscle weight loss (24) and have been suggested as necessary for rapid atrophy (5, 13) . Recent evidence indicates that atrogene regulation can vary between fast and slow muscles. For instance, the greater sensitivity of the fast-twitch muscles to fasting can be explained, at least in part, by their lower content of PGC-1␣ (peroxisome proliferator-activated receptor-␥ coactivator 1␣), known to inhibit atrogin-1 expression and fiber atrophy (26, 39) . Consistent with a fiber typedependent distribution of atrogenes, Moriscot et al. (33) have shown in mice that MuRF1 is preferentially induced in type II muscle fibers after denervation compared with soleus muscle with mixed fiber-types.
In addition to atrogin-1 and MuRF1, autophagy-related genes [microtubule-associated protein-1 light chain 3␤ (LC3b) and ␥-aminobutyric acid (GABA) receptor-associated proteinlike 1 (GABARAPl1)] and an increased capacity for lysosomal proteolysis (4) have been implicated in many forms of atrophy, including fasting (51) .
It is well established that the expression of atrogenes and autophagy-related genes is inhibited by the insulin-like growth factor I (IGF-I)-insulin-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway through the phosphorylation and nuclear exclusion of forkhead box class o (Foxo) transcription factors (38, 42) . Although cAMP-dependent protein kinase (PKA) is the most commonly examined epinephrine effector in skeletal muscle (31) , recent in vitro studies have shown that the production of cAMP by epinephrine in fast-twitch skeletal muscle (3) may activate Akt and inhibit Foxo transcription factors. Furthermore, the acute and chronic administration of clenbuterol, a selective ␤ 2 -agonist, to rodents suppressed the gene expression of atrogin-1 and MuRF1 in fast-twitch muscles following fasting (14) and denervation (15) , and these effects were likely mediated by cAMP. Drugs that induce an increase in the intracellular concentrations of cAMP, such as the selective and nonselective cAMP-phosphodiesterase (PDE) inhibitors, have been shown to prevent muscle atrophy in vivo (18) and to reduce UPS activity and atrogin-1 mRNA levels in muscles from normal and fasted rats in vitro (28) . On the basis of these findings, we propose that epinephrine may negatively regulate the fasting-induced activation of UPS through a cAMP-Akt-dependent pathway.
To investigate the specific role of epinephrine in the control of skeletal muscle protein metabolism in rodents, we have been using a model of surgical sympathectomy in which the adrenal medulla is removed. These animals are completely deficient in epinephrine but do not show any changes in the activities of the lysosomal and UPS systems under basal energy conditions (35) . The purpose of this study was to examine the role of epinephrine in the setting of fasting, particularly with regard to protein metabolism, the expression of genes and proteins involved in muscle atrophy and autophagy, and Akt/Foxo signaling. We found that plasma epinephrine depletion is associated with abnormal fasting-induced protein breakdown and atrogene expression in fast-twitch skeletal muscles, which may be consistent with a defect in Akt signaling.
MATERIALS AND METHODS
Animals and adrenodemedullation surgery. The incubation procedure required intact muscles of a sufficient thinness to allow for adequate diffusion of metabolites and oxygen; thus, fed 4-wk-old male Wistar rats (ϳ100 g) were used for all experiments. A separate group of rats (ϳ250 g) was used for the microdialysis experiments. The following four experimental groups were used: 1) sham-operated fed rats (fed), 2) adrenodemedullated fed rats (ADMX fed), 3) sham-operated fasted rats (fasted), and 4) adrenodemedullated fasted rats (ADMX fasted). The fasted groups of rats were left without food for 48 h. This animal model of muscle atrophy was chosen because it induces significant muscle weight loss that is associated with a drastic increase in Ub-ligase mRNA levels. A separated group of animals was killed after 24 or 36 h of fasting for the analysis of muscle mass and cross-sectional area of muscle fibers. ADMX was performed bilaterally under xylazine-ketamine anesthesia (10 and 85 mg/kg body wt ip, respectively) 10 days prior to use of the rats in experiments. Each adrenal medulla was squeezed through a nick made on its capsula. The animals did not require saline in their drinking water after surgery. Sham-operated rats were used as controls. Food consumption was not altered as a result of surgery. All animals were housed in a room with a 12:12-h light-dark cycle and were given free access to water and a normal chow diet. All experiments and protocols were performed in accordance with the ethical principles of animal research adopted by the Brazilian College of Animal Experimentation (COBEA) and were approved by the Ribeirão Preto Medical School of the University of São Paulo -Ethical Commission of Ethics in Animal Research (CETEA; n o 087/2010). Isolated skeletal muscles. The EDL and soleus muscles were rapidly dissected, weighed, and maintained at approximately their resting length by securing the tendons in aluminum wire supports. Tissues were incubated at 37°C in Krebs-Ringer bicarbonate buffer (pH 7.4) equilibrated with 95% oxygen and 5% carbon dioxide; the buffer contained 5 mM glucose.
Rates of protein synthesis. EDL and soleus muscles were incubated as described above in a buffer that contained all amino acids at concentrations similar to those of rat plasma (40) . After a 1-h equilibration period, L-[U-
14 C]tyrosine (0.05 Ci/ml) was added to the replacement medium, and the muscles were incubated for an additional 2 h. At the end of this period, the specific activity of acid-soluble tyrosine (intracellular tyrosine pool) in each muscle was estimated by measuring the radioactivity and the concentration of tyrosine in this pool, which was determined by the method described by Waalkes and Udenfriend (47) . After measuring the radioactivity incorporated into the protein of the same muscle, the rate of synthesis was calculated using the specific activity of the intracellular pool of tyrosine for each muscle, assuming that there was no recycling of the label during the incubation period (11) .
Protein degradation measurements. Briefly, overall proteolysis and the activities of the proteolytic systems (UPS, lysosomal, and Ca ϩ2 dependent) were measured by tracking the tyrosine released into the medium in the presence of cycloheximide (0.5 mM), which prevented protein synthesis and reincorporation of tyrosine. Tissues were preincubated for 1 h and then incubated for 2 h in identical fresh medium. Because muscle cannot synthesize or degrade tyrosine, its release reflects protein breakdown. Overall proteolysis was evaluated by measuring the amount of tyrosine released into the medium. To measure UPS activity, muscles from one limb were incubated in conditions that prevent activation of the lysosomal (10 mM methylamine and 1 U/ml insulin), branched-chain amino acid-dependent (170 M leucine, 100 M isoleucine, and 200 M valine), and Ca 2ϩ -dependent (Ca 2ϩ -free medium with cysteine-protease inhibitors, including 50 M leupeptin) proteolytic systems. In addition, muscles from the contralateral limb were incubated with the proteasome inhibitor MG132 (20 M). For lysosomal proteolysis measurements, muscles from one limb were incubated in the absence of methylamine, insulin, and branched-chain amino acids, conditions that activate the lysosomal system. Contralateral muscles were incubated in the presence of insulin (1 U/ml), leucine (170 M), isoleucine (100 M), valine (200 M), and methylamine (10 mM). Methylamine is a weak base that is transported across the cellular membranes through the ammonium transporter AmtB (48) and increases intralysosomal pH and inhibits lysosomal proteolysis. To measure Ca 2ϩ -dependent proteolytic activity, muscles from one limb were incubated in the presence of Ca 2ϩ and inhibitors of the lysosomal system (methylamine, insulin, and branched-chain amino acids), whereas contralateral muscles were incubated in a Ca 2ϩ -free medium that contained lysosomal inhibitors and cysteine-protease inhibitor (25 M leupeptin). UPS, lysosomal, and Ca 2ϩ -dependent proteolytic activities were calculated according to the difference in released tyrosine between the left and right muscles. Tyrosine release was assayed using the previously described fluorometric method (47) .
Quantitative PCR. EDL and soleus muscles were harvested and immediately frozen in liquid nitrogen. RNA was subsequently isolated from individual skeletal muscles using TRIzol (Invitrogen, Carlsbad, CA). Reverse transcription of RNA to cDNA was performed using 2 g of total cellular RNA, 20 pmol of oligo(dT) primer (Invitrogen), and Advantage ImProm-II reverse transcriptase (Promega, Madison, WI). Real-time PCR was performed using an ABI 7000 sequence detection system (Applied Biosystems, Foster City, CA), a SuperScript III Platinum SYBR Green One-Step RT-qPCR Kit with ROX (Invitrogen), and primers for rat atrogin-1 (forward 5=-GCA GAG AGT CGG CAA GTC-3= and reverse 5=-CAG GTC GGT GAT CGT GAG-3=), MuRF1 (forward 5=-TCG ACA TCT ACA AGC AGG AA-3= and reverse 5=-CTG TCC TTG GAA GAT GCT TT-3=), GABARAPl1 (forward 5=-CCC AGT TGT GGC AGT AGA CA-3= and reverse 5=-GAC TGA TCC TGA GGC TCC TG-3=), LC3b (forward 5=-TTT GTA AGG GCG GTT CTG AC-3= and reverse 5=-CAG GTA GCA GGA AGC AGA GG-3=), or cyclophilin B (forward 5=-GCA TAC AGG TCC TGG CAT CT-3= and reverse 5=-CTT CCC AAA GAC CAC ATG CT-3=). The relative quantification of mRNA levels was plotted as the fold increase compared with the values of the fed group. Transcripts of interest were normalized to cyclophilin B and RPL39 levels, and target transcript mRNA levels were calculated using the standard curve method (8) .
Western blotting analysis. EDL and soleus muscles were homogenized in 50 mM Tris·HCl buffer (pH 7.4) containing 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 10 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM sodium orthovanadate, 5 g/ml aprotinin, 1 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride at 4°C. The homogenate was centrifuged at 21,000 g at 4°C for 20 min, and the supernatant was retained. Protein content was determined using BSA as a standard (30) . An equal volume of sample buffer (20% glycerol, 125 mM Tris·HCl, 4% SDS, 100 mM dithiothreitol, 0.02% bromophenol blue, pH 6.8) was added to the supernatant, and the mixture was boiled. Epinephrine and muscle proteolysis studies. To investigate the in vitro effect of epinephrine on the rate of overall proteolysis, Ub ligases and autophagy-related gene mRNA expression, soleus and EDL muscles from fed and/or fasted rats were incubated in the presence of varying epinephrine concentrations (10 Ϫ6 , 10 Ϫ5 , or 10 Ϫ4 M) using the same procedure described above. Microdialysis studies. Fasted and ADMX fasted rats (ϳ250 g) were anesthetized with sodium thionembutal (50 mg/kg body mass ip) and placed on heating pads to maintain a temperature of 37°C. The trachea was cannulated to facilitate respiration. A polyethylene catheter (PE-50; Becton-Dickinson, Franklin Lakes, NJ) was placed in the left carotid artery for the withdrawal of blood samples and to obtain measurements of blood pressure. A microdialysis probe was inserted into the tibialis anterior muscle, and an equilibration period of 30 min was allowed. The principle of microdialysis has been described previously in detail (46) . In our study, catheters of single dialysis tubing (18 ϫ 0.3 mm, Gambro, Cuprophane, 3,000 molecular mass cutoff, Sweden) were glued to polyethylene tubing (standardized length of 50 mm). After connecting the catheter inlet to a microinjection pump (Insight EFF 311; Insight Equipments, Ribeirão Preto, Brazil), the system was perfused with 0.5% bovine albumin, 1 mM glucose, and 50 M tyrosine in isotonic saline at a rate of 1 l/min. Muscle dialysate (40 l) and arterial blood (100 l) samples were collected for measurements at the end of the 90-min microdialysis session. Tyrosine was assayed using a fluorometric method (47) . Because skeletal muscle cannot synthesize or degrade tyrosine, its concentration in muscle reflects the net balance between protein synthesis and degradation (16) . An increase in the concentration of tyrosine in the interstitium would indicate a shift in the balance toward net degradation. An in vivo probe was used to assess recovered tyrosine in all samples according to the internal reference calibration technique (29) .
Hemodynamic parameters. MEAN ARTERIAL PRESSURE. The left carotid artery was cannulated and connected to a pressure transducer (Braille Biomedical, São José do Rio Preto, Brazil) to measure mean arterial pressure (MAP) every 20 min throughout the experiment.
MUSCLE BLOOD FLOW (MBF). Blood flow changes around the microdialysis probe were measured using the previously described ethanol method (17) . Each experiment included 120 min of perfusion with isotonic saline containing 0.5% bovine albumin, 1 mM glucose, and 5 mM ethanol. Dialysate samples were collected every 15 min throughout the experiment. The ethanol concentration was determined using the YSI 2700 select biochemical analyzer (Yellow Springs, OH).
NE turnover rates. Muscle NE turnover rate was measured in vivo according to the decline in tissue NE levels following inhibition of catecholamine synthesis after treatment with DL-␣-methyl-p-tyrosine methyl ester (␣-MT, Sigma). After 0, 6, and 12 h of ␣-MT intraperitoneal administration the rats were euthanized, and the EDL and soleus muscles were removed to determine NE content determination by HLPC (12) . Briefly, tissues were homogenized in 0.2 N perchloric acid containing the antioxidants EDTA and sodium metabisulfite. Dihydroxybenzylamine was used as internal standard. After proteins were removed by centrifugation, catecholamines were adsorbed in alumina, eluted with 0.1 N perchloric acid, and isolated via HPLC (LC-7A, Shimadzu Instruments) with a Spherisorb ODS-2 (5 m, Sigma-Aldrich) reversed-phase column. NE and the internal standard were quantified using an electrochemical detector (LC-ECD-6A, Shimadzu).
Catecholamine, glucose, hormone, and muscle cAMP levels. A group of rats was killed by decapitation to determine the plasma levels of catecholamines, hormones, and glucose. Plasma was stored at Ϫ70°C prior to analysis. Catecholamines were assayed using the HPLC method described above (LC-7A, Shimadzu Instruments) with a Spherisorb ODS-2 (5 m, Sigma-Aldrich) reversed-phase column. Glucose concentrations were determined using the YSI 2700 select biochemical analyzer (Yellow Springs, OH). Free fatty acids (FFA) were determined by spectrophotometry using a Randox NEFA kit (Randox Laboratories, Crumlin, County Antrim, UK). Insulin and corticosterone were measured by radioimmunoassay, and muscular cAMP levels were measured using a method based on a competitive enzyme immunoassay system (GE Healthcare).
Skeletal muscle cross-sectional area measurements. Rats were killed, and EDL muscles were carefully harvested, snap-frozen in isopentane, and stored in liquid nitrogen at Ϫ80°C depending on the intended experiments. Muscles were cut into 5-m-thick transverse sections with a Leica CM1850 UV cryostat at Ϫ25°C (Leica Microsystems, Wetzlar, Germany); slices were then placed on 26 ϫ 76-mm slides and stained with hematoxylin and eosin. Muscle fiber sizes were calculated using ImageJ software (v. 1.45s, National Institutes of Health). Approximately 300 EDL muscle fibers from each rat were measured, and the images were captured using an optical microscope (Leica DM 2500) with a digital video camera (Leica DFC 300FX) connected to a computer.
Antibodies, drugs, and reagents. Rabbit polyclonal anti-p-Ser 473 -Akt, anti-p-Thr 308 -Akt, anti-Akt, anti-p-Ser 253 -Foxo3a, anti-Foxo3a, and anti-p-Ser 133 -CREB Abs were purchased from Cell Signaling Technology (Danvers, MA). Rabbit anti-atrogin-1, anti-GABARAP, and anti-␤-actin Abs were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-LC3 Ab was purchased from Medical and Biological Laboratories (Nagoya, Aichi, Japan). Rabbit anti-goat IgG and goat anti-rabbit IgG antibodies (secondary antibodies) were purchased from Santa Cruz Biotechnology and Cell Signaling, respectively. All drugs and reagents were purchased from Sigma-Aldrich (St. Louis, MO), Thermo Scientific HyClone (Pittsburgh, PA), Invitrogen (Carlsbad, CA), Calbiochem EMD Biosciences (La Jolla, CA), or Amersham Biosciences (Piscataway, NJ).
Calculations. The recovery factor is the permeability of the microdialysis catheter and is calculated from the concentration in the dialysate/concentration outside the catheter. In the present study, the internal reference technique was used for in vivo calibration of microdialysis catheters. This method has been validated in other microdialysis studies (27, 29) and predicts that the outflux fraction of the labeled metabolite added in the perfusate is the same as its relative recovery. Briefly, the in vivo recovery from the microdialysis catheters was determined for all samples and was calculated according to the ratio of the tyrosine (Tyr) concentration in the dialysate to that in the perfusate. To calibrate the catheters, [ 14 C]tyrosine (ϳ2.500 dpm, 0.05 mmol/l) was added to the perfusate, and the fractional extraction of radioactivity (%recovered at each period) was measured.
The following formula was used to calculate the interstitial Tyr concentration:
Changes in blood flow are expressed as the ethanol outflow/inflow ratio (e.g., the ethanol concentration in the dialysate with respect to the perfusate).
Statistical analysis. The data are presented as means Ϯ SE. Multiple comparisons were made using a one-way ANOVA followed by a Student-Newman-Keuls post hoc test or a two-way ANOVA followed by a Holm-Sidak post hoc test. P Յ 0.05 was considered to represent significance. In the turnover experiments, the data were subjected to ANOVA and ANCOVA, with P Ͻ 0.05 as criterion of significance. The slope (fractional NE turnover rate, k) of the decline in endogenous NE over time after ␣-MT injection was calculated using method of least squares. Comparison of regression line slopes was made with ANOVA. Fractional turnover rates were compared using ANCOVA. NE turnover rates were calculated as the product of fractional turnover rate and the endogenous NE content at time zero. (7) 456 Ϯ 26# (7) 641 Ϯ 23* (7) 397 Ϯ 33& (7) RWAT, g/100 g 546 Ϯ 41 (7) 241 Ϯ 24# (7) 368 Ϯ 47* (7) 228 Ϯ 22& (7) (7) 21 Ϯ 1 (10) FFA, nmol/ml 1.6 Ϯ 0.05 (7) 3.4 Ϯ 0.4# (7) 6.6 Ϯ 0.6* (7) 4.1 Ϯ 0.9 (7) Muscle cAMP, fmol/mg 611 Ϯ 45 (7) 695 Ϯ 58 (7) 871 Ϯ 60* (7) 518 Ϯ 38& (7) Values are means Ϯ SE; nos. in parentheses, n. ADMX, adrenomedullation; EWAT, epididymal white adipose tissue; RWAT, retroperitonial white adipose tissue; FFA, free fatty acids; ND, not detectable. *P Յ 0.05, Fasted vs. For comparison of turnover rates, 95% confidence intervals were determined as previously described (45) .
RESULTS
Effects of ADMX on body, fat, and skeletal muscle mass. The body mass in fed rats was not affected by ADMX (Table 1) . Compared with the fed sham-operated group, the EDL mass was decreased significantly by 10% in the ADMX fed group (Fig. 1, C and D) , whereas soleus muscle mass did not change (data not shown). After 48 h of fasting, all animals had survived, and the ADMX and sham-operated animals had both lost a similar degree of body mass (ϳ40%) and fat mass (ϳ25%). As shown in Fig. 1A , notable EDL muscle loss was observed with fasting in the sham-operated animals (6, 8, and 20% after 24, 36, and 48 h of fasting, respectively). Soleus muscle mass in the ADMX and sham-operated groups was not changed after 24 h of fasting, but it decreased significantly by 9% after 36 and 48 h of fasting in both groups (Fig. 1B) . ADMX in rats fasted for 36 h amplified the EDL muscle mass loss (Fig. 1B ) and the lower cross-sectional area of muscle fibers (Fig. 1, C and D) but did not interfere with the effects of fasting for 24 and 48 h on muscle mass in EDL (Fig. 1A) .
Effects of ADMX on metabolic and hormonal parameters. ADMX in fed rats induced a marked reduction in the wet mass of epididymal and retroperitoneal white adipose tissue as well as an increase in plasma FFA levels, which suggests that these rats underwent active lipolysis ( Table 1 ). The fasting state in shamoperated animals decreased plasma glucose levels (ϳ40%), depleted insulin levels, and increased FFA levels (ϳ3-fold), corticosterone levels (ϳ2-fold), and cAMP levels in the EDL muscle (ϳ42%). Similar responses were observed in the fasted ADMX group compared with the fed ADMX group, with the exception of the fasting-induced increase in muscle cAMP levels that was not observed in the ADMX group and the FFA that was already high in the fed ADMX group (Table 1) .
Effect of ADMX on plasma catecholamines and NE turnover in skeletal muscles. The effect of ADMX was confirmed by a drastic reduction in plasma epinephrine concentration (ϳ90%) but not NE concentration ( Fig. 2A) . However, caution should be taken in asserting that plasma NE levels were not affected by ADMX, given that the blood was collected by decapitation, a stressful condition that can activate the sympathetic activity in different tissues and increase the circulating pool of NE (22) . To further characterize the functional compensation of the adrenal medulla by the sympathetic nerves (44), the effects of ADMX on NE turnover in the EDL and soleus muscles were studied in fed and fasted rats. There was no difference in baseline sympathetic activity between the EDL and soleus muscles in the sham group (Fig. 3) . However, the rate of NE turnover in both the EDL and soleus muscles in fed rats was significantly increased following bilateral adrenal removal (Fig. 3, A and C) , which indicates that plasma epinephrine depletion for 10 days in rats leads to compensatory activation of sympathetic nerve terminals in skeletal muscles under basal energy conditions. Fasting did not affect the plasma concentrations of catecholamines (Fig. 2) but significantly decreased sympathetic activity in the EDL (Fig. 3B) . NE turnover in the soleus tended to decrease in fasted animals, but this difference did not attain statistical significance. In ADMX rats, the sympathetic activity in both the EDL and soleus muscles was similarly decreased due to fasting (Fig. 3 , B and D; Table 2 ).
Effects of ADMX on rates of protein synthesis and protein degradation. Skeletal muscle protein metabolism in ADMX rats varied according to the nutritional state of the animals and the muscle type examined. As expected, fasting increased the levels of proteolysis (ϳ30%) in the EDL (Fig. 4A ) and decreased the rate of protein synthesis in both the soleus (33%) and EDL (50%) muscles of sham-operated rats (Fig. 4B) . Epinephrine depletion in fed rats did not affect the release of tyrosine in the EDL but led to an additional increase (ϳ30%) in overall fasting-induced proteolysis (Fig. 4A) . ADMX in fed rats induced a 20% increase in the rate of protein synthesis in both the EDL and soleus muscles (Fig. 4B ) but did not affect the low rate of protein synthesis in the muscles of fasted rats (Fig. 4B) . The rate of protein degradation in the soleus muscle was not affected by either fasting or ADMX (Fig. 4A) .
Effects of ADMX on proteolytic pathways and markers of atrophy and autophagy. To further investigate the mechanisms underlying ADMX-induced exacerbation of overall proteolysis in EDL muscle under fasting conditions, the activity of proteolytic pathways and the mRNA and protein levels of atrophyrelated Ub-ligases atrogin-1 and MuRF1 and autophagy-related proteins LC3 and GABARAP were assessed. The increased rates of protein degradation observed in EDL muscle from fasted rats were accompanied by elevated UPS activity (Fig. 5A) . ADMX treatment amplified the proteolytic effect of fasting on UPS activity in EDL muscle ϳ2-fold (Fig. 5A ) but had no effect on the fasting-induced increase in UPS activity in soleus muscle (0.196 Ϯ 0.015 in ADMX fasted vs. 0.177 Ϯ 0.011 nmol Tyr·mg Ϫ1 ·2 h Ϫ1 in fasted rats; n ϭ 7, P Ͼ 0.05). Furthermore, lysosomal proteolytic activity in EDL muscle from the sham group was not altered as a result of fasting (Fig. 5A ) but was significantly increased by ϳ50% in EDL muscles from ADMX fasted rats (Fig. 5A) . No significant effect was observed on Ca ϩ2 -dependent proteolytic activity in skeletal muscles from any group (Fig. 5A ). As shown in Fig. 5 , fasting increased the mRNA levels (Fig. 5B ) and protein contents (Fig. 5, C and D) of atrogin-1, MuRF1, LC3, and GABARAP, whereas ADMX did not affect the expression of atrophy and autophagy markers in muscles from fed rats. However, ADMX led to a further increase in the mRNA levels (Fig. 5B ) of atrogin-1 (ϳ3-fold), MuRF1 (ϳ3-fold), LC3b (ϳ5-fold), and GABARAPl1 (ϳ4-fold) and in the protein content (Fig. 5C ) of MuRF1 (ϳ3-fold) and the active, autophagosome membrane-bound form, LC3-II (ϳ5-fold) in EDL muscles from fasted rats. These effects on gene expression were not accompanied by alterations in the protein levels of atrogin-1 and GABARAP (Fig. 5, C and D) . Table 2 for fractional turnover rates (k) and rates of NE turnover (TR). Half-time of NE disappearance (t1/2) ϭ 0.693/k. In soleus, ADMX did not affect the fasting-induced increase in atrogin-1 and LC3b mRNA levels (data not shown). These data demonstrate that plasma epinephrine depletion exacerbates the fasting-induced activation of UPS and the autophagy/lysosomal proteolytic systems in fast-twitch muscles. Effects of ADMX on Akt/Foxo signaling. Because Akt/Foxo signaling has recently been proposed to mediate the actions of epinephrine and ␤ 2 -agonists on protein metabolism (15, 21) , we analyzed the phosphorylation status of Akt and Foxo3a in EDL and soleus muscles by immunoblotting. The results indicated that fasting reduced the phosphorylation levels of Akt (at Thr but not Ser) in EDL muscle (Fig. 6, A and B) , and ADMX also decreased the phosphorylation levels of Akt (at both sites) in EDL muscle from fed rats and further decreased the phosphorylation levels in muscles from fasted rats (Fig. 6, A and B) . Interestingly, this effect was not observed in soleus muscles from either ADMX fed or fasted rats (data not shown). The phosphorylation levels of Foxo3a in EDL muscle from sham rats were also reduced as a result of fasting, but ADMX treatment had no effect on either fed or fasted rats (Fig. 6, A  and B) . Together, these findings indicate that plasma epinephrine depletion amplifies the decrease in the Akt phosphorylation levels induced by fasting in EDL muscle.
Effects of ADMX on in vivo protein metabolism balance, akt signaling, and hemodynamic parameters. Microdialysis experiments in the fasted and ADMX fasted groups were conducted to verify whether plasma epinephrine depletion could affect the in vivo protein metabolism balance, Akt signaling, muscle blood flow, and/or MAP in adult rats. In both experimental groups, skeletal muscle interstitial levels of tyrosine were significantly higher than arterial plasma tyrosine levels (Fig. 7A) , indicating a net release of tyrosine from muscles. In addition, ADMX fasted rats had significantly higher concentrations of interstitial tyrosine (50%) compared with fasted rats (Fig. 7A) , although arterial plasma tyrosine levels did not differ between the groups (Fig. 7A) . Moreover, the difference between interstitial and arterial plasma tyrosine concentrations in skeletal muscle was significantly increased (ϳ2-fold) in ADMX fasted rats compared with fasted rats (Fig. 7A) . ADMX also decreased the phosphorylation of Akt (at Ser 473 residue) in the tibialis muscle of fasted rats relative to that in sham-operated fasted rats (Fig. 7B) . MBF, estimated by the ethanol outflow/inflow concentration ratio, and MAP were not altered by ADMX treatment. Cumulatively, these data suggest that ADMX treatment increases protein catabolism in fasted adult rats independently of hemodynamic changes, and this effect is associated with low levels of Akt phosphorylation.
In vitro effects of epinephrine on rates of protein degradation and on mRNA expression of atrogenes and autophagyrelated genes. Various concentrations of epinephrine were added to the incubation medium of EDL muscle isolated from fasted rats. As shown in Fig. 8, A and B , fasting increased the rates of protein degradation and the mRNA levels of atrogin-1 (ϳ25-fold), MuRF1 (ϳ10-fold), LC3b (ϳ4-fold), and GABARAPl1 (ϳ6-fold). Furthermore, the addition of 10 Ϫ6 , 10 Ϫ5 , and 10
Ϫ4
M epinephrine to the incubation medium reduced the rates of total protein degradation by 15, 30, and 25%, respectively (Fig.  8A) . All concentrations of epinephrine tested significantly downregulated the fasting-induced increase of atrogin-1 mRNA levels, whereas the MuRF1 mRNA levels returned to basal levels only in response to the highest concentration of the hormone (10 Ϫ4 M; Fig. 8B ). LC3b and GABARAPl1 expression in muscles from fasted rats incubated with epinephrine tended to be at a lower level, although this decrease in expression was not statistically significant compared with fasted rat muscle incubated in the absence of epinephrine. In addition, 10 Ϫ6 , 10 Ϫ5 , and 10 Ϫ4 M epinephrine inhibited the fastinginduced activity of UPS in EDL muscle by 50, 35, and 28%, respectively, whereas the highest concentration of epinephrine (10 Ϫ4 M) did not interfere with this proteolytic activity in soleus muscle (0.123 Ϯ 0.018 in fastedϩADR vs. 0.144 Ϯ 0.012 nmol Tyr·mg Ϫ1 ·2 h Ϫ1 in fasted rats, n ϭ 7, P Ͼ 0.05). These in vitro results are consistent with the in vivo data and demonstrate that epinephrine is able to directly suppress the UPS activity and the expression of atrogin-1 and MuRF1 mRNA in EDL muscle induced as a result of 48 h of food deprivation.
DISCUSSION
This study is the first to show that chronic depletion of epinephrine in juvenile and adult rats exacerbates long-term fasting-induced protein catabolism in fast-twitch skeletal muscles. In accord with previous studies (20, 49) , our data demonstrate that the loss of muscle mass following 48 h of fasting in sham-operated rats was due to the activation of proteolysis and a reduction in protein synthesis. These well-known catabolic events were more pronounced in the EDL than in the soleus muscle and were associated in EDL with the suppression of muscle sympathetic activity, as estimated by NE turnover. Although these data correlate well with the loss of muscle mass that was higher in EDL than in soleus, they do not allow us to make any conclusion that the fall in the EDL sympathetic activity might contribute to the muscle wasting. One possible rationale for such a pattern of sympathoadrenal response is that the reduction in sympathetic activity in fasttwitch muscles reduces the rate of energy utilization, whereas the maintenance of adrenomedullary secretion and cAMP increase sustains essential catecholamine-dependent processes, such as lypolysis and glycogenolysis, at a lower net energy cost (22) . However, the role of epinephrine in the control of muscle protein metabolism in the setting of starvation is not known. We observed that the plasma depletion of epinephrine by ADMX in fasted rats amplified overall proteolysis and further increased the activity of UPS. Epinephrine depletion also increased the mRNA levels of atrogin-1 and MuRF1 and led to elevated MuRF1 protein levels in EDL muscle. In contrast to MuRF1, the protein content of atrogin-1 was not affected by ADMX, most likely because of the inherent instability of its mRNA. Indeed, atrogin-1 mRNA is relatively short-lived (halflife of 1 h), whereas MuRF1 mRNA is relatively long-lived (41) . The amplification of fasting-induced catabolic effects on Fig. 5 . Effects of ADMX for 10 days on proteolytic activities of the ubiquitin (Ub)-proteasome system (UPS), lysosomal, and Ca 2ϩ -dependent proteolytic systems (A), mRNA expression levels (B), and protein expression levels (C) in EDL muscles from fed and 2-day-fasted rats. Proteolytic activity was estimated as the difference between the amount of tyrosine released from muscles incubated in the presence or absence of specific proteolytic system inhibitors (see MA-TERIALS AND METHODS). Gene expression levels were analyzed using cyclophilin B as an endogenous control. For immunoblotting, membranes were stripped and reprobed for ␤-actin as a loading control. Densitometry values (C) and representative immunoblots (D) are shown in top and botton, respectively Data are presented as means Ϯ SE of 7 muscles. *P Յ 0.05, fasted vs. fed; &P Յ 0.05, ADMX fasted vs. fasted. proteolysis in ADMX rats occurred without any changes in muscle blood flow, as estimated by microdialysis, hypoglycemia, or plasma insulin and glucocorticoid levels. Thus, the catabolic effects were likely the direct consequence of a reduction in plasma epinephrine levels. This mechanism is consistent with the inhibition of fasting-induced proteolysis and atrogene expression observed upon the addition of epinephrine in vitro and with the repeatedly demonstrated inhibitory effect of epinephrine and ␤ 2 -agonists on muscle proteolysis in humans (31) and rodents (14) . The inhibitory effects of epinephrine on UPS seem to be mediated by cAMP, and similar effects on overall proteolysis have been observed with dibutyrylcAMP, which is a cAMP analog (35) , and 6-BNZ-cAMP, which is a selective PKA agonist (15) . This mechanism is also consistent with the present finding that muscle cAMP levels, which were already high in the fasted group, were significantly reduced by ADMX as well as being consistent with previous studies showing that the increase in cAMP levels that is induced by cAMP-PDE inhibitors prevents the fasting-induced increase in UPS in isolated muscles (3, 24) and blocks dexamethasone-induced atrogin-1 expression in cultured muscle cells (14) . Other in vivo studies have shown that daily administration of either clenbuterol or pentoxifylline prevents muscle atrophy by suppressing increased UPS activity in Yoshida sarcoma-bearing (9), diabetic (1), and denervated rats (15) . The present data also show that removal of the medulla in fasted rats not only amplified the UPS activity but also resulted in hyperactivation of the lysosomal system (Fig. 5A) , which was altered neither in sham-operated fasted rats nor in ADMX fed rats. This effect was accompanied by the additional upregulation of the autophagy-related genes LC3b and GABARAPl1 and the active form of LC3, LC3-II. A similar increase in UPS activity and the hyperactivation of lysosomal proteolysis by chemical sympathectomy have been previously reported for muscles from diabetic rats (2) . Collectively, these findings suggest that epinephrine plays a role in suppressing UPS and lysosomal/autophagic activity during fasting conditions via cAMP/PKA signaling, most likely through a decrease in atrogene expression. It is noteworthy that the EDL of ADMX rats did not demonstrate further atrophy after 48 h of food deprivation even when confronted with increased UPS activity and atrogene expression. However, we observed that the plasma depletion of epinephrine by ADMX in fasted rats for 36 h amplified the muscle mass loss, suggesting that the EDL muscle loss upon 48 h had reached maximum values in ADMX fasted and sham fasted animals.
It is well established that insulin negatively regulates the induction of UPS and lysosomal/autophagic activities via Akt signaling and the inactivation of Foxo3a and Foxo1 (38, 42) . More recently, we and others have demonstrated that ␤ 2 -adrenergic agonist treatment activates Akt and its downstream targets to induce muscle growth (21) and suppress muscle loss during unloading and denervation (15, 21) . This muscle-sparing effect occurs through the inhibition of lysosomal and UPS proteolysis, which is accompanied by the suppression of genes controlling atrophy (15) . Thus, we hypothesized that the inhibitory effect of epinephrine on atrogenes is mediated through cAMP, which leads to the activation of Akt and the inhibition of the forkhead transcriptional program. Accordingly, the low levels of phosphorylated Akt (at a Thr residue) in muscles from fasted rats were further reduced by ADMX (Fig. 6 ). This additional decrease in Akt phosphorylation was a direct consequence of plasma epinephrine depletion, which was indicated in previous reports. First, epinephrine addition in vitro was shown not only to induce basal Akt and Foxo3a phosphorylation but also to dramatically amplify insulin-stimulated phosphorylation of these intermediates in isolated EDL muscle (3) and cardiomyocytes (43) . Second, Akt phosphorylation has been observed in muscles from clenbuterol-injected wild-type fed mice but not in ␤ 2 -adrenoceptor knockout mice (14) . These data indicate that insulin and epinephrine use similar mechanisms, likely via Akt, to exert inhibitory effects on UPS and lysosomal/autophagic pathways and suggest that the two hormones interact to control these proteolytic processes. Although our data show that ADMX treatment did not affect the low phosphorylation levels of Foxo3a in EDL muscle from fasted rats, we cannot conclude that epinephrine suppresses Ub-ligase levels via a Foxo-independent mechanism. It is likely that a further decrease in phosphorylated Foxo occurred prior to the 48 h of fasting, and this supposition is supported by the finding that the phosphorylated levels of Akt and Foxo3a increased in muscles from fasted mice as soon as 4 h after clenbuterol injection (14) .
Despite the recognized importance of Akt signaling in the regulation of growth and protein synthesis (10, 34), our data indicate that the fasting-induced decrease in protein synthesis was comparable between sham-operated and ADMX rats. These data are difficult to interpret, given that the rate of muscle protein synthesis in fed animals was already increased by ADMX. The observed increase cannot be explained by increased insulin sensitivity because p-Akt levels in the EDL were decreased by ADMX. Because sympathetic innervation has been shown to stimulate the basal rate of protein synthesis in skeletal muscles (36), we hypothesized that acceleration of NE turnover after ADMX could account for the higher rate of protein synthesis in the muscles of fed animals. In fact, the present data demonstrate for the first time that noradrenergic nerves of skeletal muscles are activated by ADMX in fed animals as a compensatory mechanism. These findings align with those of previous studies that found similar results in other tissues, including the pancreas and brown adipose tissue (44); our results also support the finding that ADMX fed rats exhibit an increase in active lipolysis, thus providing indirect evidence of increased noradrenergic activity in white adipose tissue. Notwithstanding the increased protein synthesis, plasma epinephrine depletion in fed rats led to a decrease in the mass and cross-sectional area of the EDL, which is consistent with a previous observation that G s ␣-deficient mice developed muscle atrophy (7) . Despite these effects, muscle cAMP levels in ADMX fed rats were similar to those in sham fed rats. Perhaps this lack of effect could be explained by the compensatory sympathetic activity induced by ADMX that was able to rescue cAMP levels but not p-Akt and muscle atrophy. The finding that basal levels of Akt phosphorylation were also reduced in Fig. 8 . In vitro effects of various epinephrine (EPI) concentrations on overall proteolysis (A) and mRNA expression of atrogenes (B) in EDL and on UPS activity in EDL from fasted rats (C). Muscles from 2-day-fasted rats were isolated and incubated with epinephrine for 2 h. Gene expression levels were analyzed using RPL39 as an endogenous control. Data are presented as means Ϯ SE of 6 muscles. *P Յ 0.05, fasted vs. fed; †P Յ 0.05, fasted ϩ EPI vs. fasted.
the EDL under basal conditions reinforces the hypothesis that epinephrine regulates protein metabolism through Akt signaling. The finding that the protein degradation rate was not altered by ADMX treatment in fed rats does not rule out the possibility that an increase in proteolysis and/or a decrease in protein synthesis occurred prior to the end of the 10-day fast, which was the only time interval examined in the present study. Indeed, we have previously shown that ADMX treatment for 3 days induces a rapid and reversible increase in overall proteolysis (35) .
One interesting finding of this study was that most of the deleterious effects of ADMX on proteolysis and Akt signaling occurred only in EDL muscle and not in soleus muscle. Unlike EDL, soleus muscle from fasted animals did not exhibit an amplification of proteolytic activities or a defect in Akt signaling after ADMX. Furthermore, epinephrine did not decrease the UPS activity in soleus muscle from fasted rats, and ADMX did not affect the muscle mass or the phosphorylation levels of Akt in soleus muscle from fed animals. It is well established that all muscles do not respond identically to stimulation by epinephrine or ␤-adrenergic agonists. For instance, fast-twitch muscles are more responsive to the hypertrophic effects of ␤-adrenoceptor agonists than slow-twitch muscles (31). This conclusion is consistent with a previous report indicating that Akt is activated by ␤ 2 -agonists in EDL muscle but not in soleus muscle (15) . Furthermore, it is likely that this lack of Akt responsiveness in soleus muscle results from the activity of PKA, which presents approximately two-to threefold higher expression and activity in the soleus than in the EDL muscle (19) and also inhibits Akt phosphorylation (3, 32) .
In summary, the present data suggest that epinephrine released from the adrenal medulla may be of particular importance for decreasing protein breakdown in fast-twitch skeletal muscles during long-term fasting. These antiproteolytic effects on the UPS and lysosomal systems in the setting of fasting are likely mediated via a cAMP-Akt-dependent pathway and may lead to the suppression of ubiquitination and autophagic flux. Finally, we show there is a functional compensatory mechanism between the sympathetic nerves and the adrenal medulla in skeletal muscles under basal conditions. Therefore, studies that do not take into account the relative importance of sympathetic nerves and adrenal medulla may underestimate the contributions of catecholamines in a given situation.
